GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Wiley  (1)
  • Neuser, Hans  (1)
  • 1
    In: European Journal of Heart Failure, Wiley, Vol. 21, No. 9 ( 2019-09), p. 1103-1113
    Abstract: Cardiac contractility modulation (CCM) improves symptoms and exercise tolerance and reduces heart failure (HF) hospitalizations over 6‐month follow‐up in patients with New York Heart Association (NYHA) class III or IV symptoms, QRS 〈  130 ms and 25% ≤ left ventricular ejection fraction (LVEF) ≤ 45% (FIX‐HF‐5C study). The current prospective registry study (CCM‐REG) aimed to assess the longer‐term impact of CCM on hospitalizations and mortality in real‐world experience in this same population. Methods and results A total of 140 patients with 25% ≤ LVEF ≤ 45% receiving CCM therapy (CCM‐REG 25‐45 ) for clinical indications were included. Cardiovascular and HF hospitalizations, Minnesota Living with Heart Failure Questionnaire (MLHFQ) and NYHA class were assessed over 2 years. Mortality was tracked through 3 years and compared with predictions by the Seattle Heart Failure Model (SHFM). A separate analysis was performed on patients with 35% ≤ LVEF ≤ 45% (CCM‐REG 35‐45 ) and 25% ≤ LVEF  〈  35% (CCM‐REG 25‐34 ). Hospitalizations decreased by 75% (from 1.2/patient‐year the year before, to 0.35/patient‐year during the 2 years following CCM, P   〈  0.0001) in CCM‐REG 25‐45 and by a similar amount in CCM‐REG 35‐45 ( P   〈  0.0001) and CCM‐REG 25‐34 . MLHFQ and NYHA class improved in all three cohorts , with progressive improvements over time ( P   〈  0.002). Three‐year survival in CCM‐REG 25‐45 (82.8%) and CCM‐REG 24‐34 (79.4%) were similar to those predicted by SHFM (76.7%, P  = 0.16; 78.0%, P  = 0.81, respectively) and was better than predicted in CCM‐REG 35‐45 (88.0% vs. 74.7%, P  = 0.046). Conclusion In real‐world experience, CCM produces results similar to those of previous studies in subjects with 25% ≤ LVEF ≤ 45% and QRS 〈  130 ms; cardiovascular and HF hospitalizations are reduced and MLHFQ and NYHA class are improved. Overall mortality was comparable to that predicted by the SHFM but was lower than predicted in patients with 35% ≤ LVEF ≤ 45%.
    Type of Medium: Online Resource
    ISSN: 1388-9842 , 1879-0844
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2019
    detail.hit.zdb_id: 1500332-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...